BMRN vs EIX · P/E 40, rev $2.85B vs P/E 7.3, rev $17.60B
Biomarin Pharmaceutical Inc (BMRN) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the BMRN and EIX stock pages for the full models.
Not investment advice.